Abstract
A common theme found in studies with mouse models of autoimmune diseases is that pathogenic T cells are primarily responsible for the pathology. Such models include diabetes in non-obese diabetic (NOD) mice, experimental autoimmune encephalomyelitis (EAE)—a model of multiple sclerosis (MS), collagen II (CII)-induced arthritis (CIA)—a model of rheumatoid arthritis (RA). Pathogenic T cells in EAE utilize a restricted repertoire of genes encoding the T-cell receptor (TCR) (1). For example, upon immunization of H-2u mice with either myelin basic protein, or its immunodominant fragment, peptide Ac1-20, the Vβ8.2 TCR gene product is expressed in the majority of pathogenic T cells (2–4). The restricted usage of the Vβ8.2 TCR gene product has also been found in rats in which EAE was induced by a peptide of myelin basic protein (5). Similarly, a restriction in the TCR usage was found also in CII-induced arthritis in mice (6,7), and in the TCR alpha chain usage in non-obese diabetic (NOD) mice (8).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zamvil, S. and Steinman, L. (1990) The T lymphocyte in autoimmune encephalomyelitis. Ann. Rev. Immunol. 8, 579–621.
Zamvil, S. S., Mitchell, D. J., Lee, N. E., Moore, A. C., Waldor, M. K., Sakai, K., Rothbard, J. B., McDevitt, H. O., Steinman, L., and Acha-Orbea, H. (1988) Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis. J. Exp. Med. 167, 1586–1596.
Acha-Orbea, H., Mitchell, D. J., Timmermann, L., Wraith, D. C., Tausch, G. S., Waldor, M. K., Zamvil, S. S., McDevitt, H. O., and Steinman, L. (1988) Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54, 263–273.
Urban, J. L., Kumar, V., Kono, D. H., Gomez, C., Horvath, S. J., Clayton, J., Ando, D. G., Sercarz, E. E., and Hood, L. (1988) Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54, 577–592.
Gold, D. P., Offner, H., Sun, D., Wiley, S., Vandenbark, A. A., and Wilson, D. B. (1991) Analysis of T cell receptor beta chains in Lewis rats with experimental allergic encephalomyelitis: Conserved complementarity determining region 3. J. Exp. Med. 174, 1467–1476.
Osman, G. E., Toda, M., Kanagawa, O., and Hood, L. E. (1993) Characterization of the T cell receptor repertoire causing collagen arthritis in mice. J. Exp. Med. 177, 387–395.
Banerjee, S., Haqqi, T. M., Luthra, H. S., Stuart, J. M., and David, C. S. (1988) Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J. Exp. Med. 167, 832–839.
Simone, E., Daniel, D., Schloot, N., Gottlieb, P., Babu, S., Kawasaki, E., Wegmann, D., and Eisenbarth, G. S. (1997) T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc. Natl. Acad. Sci. USA 94, 2518–2521.
Oksenberg, J. R., Panzara, M. A., Begovich, A. B., Mitchell, D., Erlich, H. A., Murray, R. S., Shimonkevitz, R., Sherritt, M., Rothbard, J., Bernard, C. C., and Steinman, L. (1993) Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362, 68–70.
Naserke, H. E., Durinovic-Bello, I., Seidel, D., and Ziegler, A. G. (1996) The T-cell receptor beta chain CDR3 region of BV8S1/BJ1S5 transcripts in type 1 diabetes. Immunogenetics 45, 87–96.
Waase, I., Kayser, C., Carlson, P. J., Goronzy, J. J., and Weyand, C. M. (1996) Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum. 39, 904–913.
Sakai, K., Sinha, A. A., Mitchell, D. J., Zamvil, S. S., Rothbard, J. B., McDevitt, H. O., and Steinman, L. (1988) Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. Proc. Natl. Acad. Sci. USA 85, 8608–8612.
Vandenbark, A. A., Hashim, G., and Offner, H. (1989) Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341, 541–544.
Howell, M. D., Winters, S. T., Olee, T., Powell, H. C., Carlo, D. J., and Brostoff, S. W. (1989) Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246, 668–670.
Moder, K. G., Luthra, H. S., Griffiths, M., and David, C. S. (1993) Prevention of collagen induced arthritis in mice by deletion of T cell receptor V beta 8 bearing T cells with monoclonal antibodies. Br. J. Rheumatol. 32, 26–30.
Chiocchia, G., Boissier, M. C., and Fournier, C. (1991) Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies. Eur. J. Immunol. 21, 2899–2905.
Waisman, A., Ruiz, P. J., Hirschberg, D. L., Gelman, A., Oksenberg, J. R., Brocke, S., Mor, F., Cohen, I. R., and Steinman, L. (1996) Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2, 899–905.
Mosmann, T. R. and Coffman, R. L. (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145–173.
Abbas, A. K., Williams, M. E., Burstein, H. J., Chang, T. L., Bossu, P., and Lichtman, A. H. (1991) Activation and function of CD4+ T-cell subsets. Immunol. Rev. 123, 5–22.
Xu, D., und Liew, F. Y. (1995) Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology 84, 173–176.
Sambrook, J., Fritsch, E. F., and Maniatis, F. (eds.) (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Waisman, A. (2000). Immunity to T-Cell Receptor. In: Lowrie, D.B., Whalen, R.G. (eds) DNA Vaccines. Methods in Molecular Medicine™, vol 29. Humana Press. https://doi.org/10.1385/1-59259-688-6:397
Download citation
DOI: https://doi.org/10.1385/1-59259-688-6:397
Publisher Name: Humana Press
Print ISBN: 978-0-89603-580-5
Online ISBN: 978-1-59259-688-1
eBook Packages: Springer Protocols